Today: 24.Feb.2018
Molybdenum 99 Production for Nuclear Medicine 2010 - 2020 Europe
17.Mar.2015
Rate this item
(0 votes)

AIPES - The radionuclides supply for nuclear medicine is crucially dependent on an unsustainably low number of production reactors and processing facilities in Europe, North America, South-Africa and Asia/Pacific.

Read 924 times Last modified on Thursday, 04 January 2018 17:02

Newsletter Subscription

  • Latest
  • Popular
  • Thomas Cochran has been working with the…
  • Charles Barton, lead advocate for advanced nuclear…
  • Rod Adams, Atomic energy expert with small…
  • Neil Alexander, Ph.D. radiation damage in steels,…
  • Neil Alexander, Ph.D. radiation damage in steels,…
  • Thomas Cochran has been working with the…
  • Charles Barton, lead advocate for advanced nuclear…